Sanofi loses challenge to Amgen patents for cholesterol-busting Repatha

Sanofi loses challenge to Amgen patents for cholesterol-busting Repatha

Save (0) Please login to bookmarkClose Username or Email Address Password Remember Me Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha. Subscribe to Lawyerly to access this article.Already a subscriber? Username or Email Address Password Remember Me Lost your password? The post San…

The pharmaceutical company Sanofi has chosen Barcelona to install its new innovation hub. Specifically, the French multinational plans to create more than 300 new highly qualified jobs in areas such as data science or artificial intelligence in a new research center that will be located at 22@ del Poblenou. Sanofi anticipates that the hub, which will also focus on the development of digital products and advanced analyses, will be operational by …

While France had missed the turn of the next generation vaccines against the Covid-19, the Sanofi project is finally taking shape. The industrial company is putting into operation a new R&D centre near Lyon, with an investment of 120 million euros.